Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04740112
Other study ID # 2021/01/7
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 28, 2021
Est. completion date June 30, 2021

Study information

Verified date March 2024
Source General Mills
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a digital clinical trial to investigate satiety and consumer preference in responses to three test breakfast bars with varying level of dietary fiber, beta-glucan, and product packages (with or without product claims) in healthy adults.


Recruitment information / eligibility

Status Completed
Enrollment 130
Est. completion date June 30, 2021
Est. primary completion date February 28, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Healthy adults 18-70 years. - Habitual snack bar consumers (consume bars at least 3 times a week). - Body mass index 20-29.9 kg/m² (based on self-reported weight and height). - Understand the study procedures. - Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial. - Willing to follow study procedures on test days. - Willing to abstain from strenuous exercise, consuming alcoholic drinks 24 hours before the test day. - Willing to provide informed consent to participate in the study. - Willing to maintain confidentiality of the study and test products. Exclusion Criteria: - Pregnant or lactating women, or women who are planning to become pregnant during the study - Known food allergies, sensitivity, or intolerance to any food or food ingredients - Participating in another clinical trial for food, investigational drug, nutritional supplement, or lifestyle modification - Taking medications that affect appetite, metabolism, or blood pressure - Taking supplements with dietary fiber - Presence of acute diseases or infection - Presence or history of chronic diseases - Diagnosed with eating disorders - Restraint eaters - Lost or gained 5 pounds or more in the past 3 months

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Foods with beta-glucan from oats and barley
Breakfast bars made with varying levels of total dietary fiber and beta-glucan, with or without claims on package image

Locations

Country Name City State
United States No physical visit to a research facility is required. Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
General Mills

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hunger Hunger as measured by visual analog scales in mm using appetite questionnaires 30 minutes after consumption
Primary Hunger Hunger as measured by visual analog scales in mm using appetite questionnaires 60 minutes after consumption
Primary Hunger Hunger as measured by visual analog scales in mm using appetite questionnaires 90 minutes after consumption
Primary Hunger Hunger as measured by visual analog scales in mm using appetite questionnaires 120 minutes after consumption
Primary Hunger Hunger as measured by visual analog scales in mm using appetite questionnaires 180 minutes after consumption
Primary Fullness Fullness as measured by visual analog scales in mm using appetite questionnaires 30 minutes after consumption
Primary Fullness Fullness as measured by visual analog scales in mm using appetite questionnaires 60 minutes after consumption
Primary Fullness Fullness as measured by visual analog scales in mm using appetite questionnaires 90 minutes after consumption
Primary Fullness Fullness as measured by visual analog scales in mm using appetite questionnaires 120 minutes after consumption
Primary Fullness Fullness as measured by visual analog scales in mm using appetite questionnaires 180 minutes after consumption
Primary Desire to eat Desire to eat as measured by visual analog scales in mm using appetite questionnaires 30 minutes after test meal consumption
Primary Desire to eat Desire to eat as measured by visual analog scales in mm using appetite questionnaires 60 minutes after test meal consumption
Primary Desire to eat Desire to eat as measured by visual analog scales in mm using appetite questionnaires 90 minutes after test meal consumption
Primary Desire to eat Desire to eat as measured by visual analog scales in mm using appetite questionnaires 120 minutes after test meal consumption
Primary Desire to eat Desire to eat as measured by visual analog scales in mm using appetite questionnaires 180 minutes after test meal consumption
Primary Prospective consumption Prospective consumption as measured by visual analog scales in mm using appetite questionnaires 30 minutes after test meal consumption
Primary Prospective consumption Prospective consumption as measured by visual analog scales in mm using appetite questionnaires 60 minutes after test meal consumption
Primary Prospective consumption Prospective consumption as measured by visual analog scales in mm using appetite questionnaires 90 minutes after test meal consumption
Primary Prospective consumption Prospective consumption as measured by visual analog scales in mm using appetite questionnaires 120 minutes after test meal consumption
Primary Prospective consumption Prospective consumption as measured by visual analog scales in mm using appetite questionnaires 180 minutes after test meal consumption
Secondary Flavor rating Subjective ratings on liking of the product flavor using Likert scales 30 minutes after test meal consumption
Secondary Sweetness rating Subjective ratings on sweetness of the product using Likert scales 30 minutes after test meal consumption
Secondary Texture rating Subjective ratings on liking of the product texture using Likert scales 30 minutes after test meal consumption
Secondary Overall product liking Subjective ratings on overall liking of the product using Likert scales 30 minutes after test meal consumption
Secondary Purchase intent Likelihood of buying the product using Likert scales 180 minutes after test meal consumption
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1